Compositions And Methods For Diagnosing And Treatng Asthma Or Other

Compositions And Methods For Diagnosing And Treatng Asthma Or Other Allergic Or Inflammatory Diseases

Abstract: The present invention provides compositions and methods useful for detecting or treating asthma or other allergic or inflammatory diseases. In one aspect, the methods of the present invention include inhibiting the activity or expression of a component of an arginine metabolic pathway in tissues affected by asthma or other allergic or inflammatory diseases. In many embodiments, the component being inhibited is a cationic amino acid transporter, an arginase, or a component downstream of the arg nase. In many other embodiments, the activity or expression of the component is i bited by an agent that binds to the component. In still many other embodiments, the activity or expression of the component is inhibited by an agent that binds a polynucleotide encoding the component.

Patent Information

Application #

Filing Date

04 December 2007

Publication Number

07/2008

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

WYETH

5 GIRALDA FARMS, MADISON, NEW JERSEY

Inventors

1. BOWMAN MICHAEL R

63 GLOUCESTER ROAD, WESTWOOD, MA 02090

2. ELLIS DEBRA

1266 PAWTUCKET BOULEVARD, LOWELL, MA 01854

3. FOLLETTIE MAXIMILLIAN T

12 GREENSBROOK WAY, BELMONT, WA 02478

4. WINKLER AARON

151 MARY STREET, ARLINGTON, MA 02474

5. WILLIAMS CARA

11 OBSERVATORY ROAD, METHUEN, MA 01844

6. CHEN HENG

129 NORTH STREET, #8, NEWTON, MA 02460

7. LIU WEI

73 BLACKMER ROAD, SUDBURY, MA 01776

Specification

The present invention provides compositions and methods useful for detecting or treating asthma or other allergic
or inflammatory diseases. In one aspect, the methods of the present invention include inhibiting the activity or expression of a
component of an arginine metabolic pathway in tissues affected by asthma or other allergic or inflammatory diseases. In many
embodiments, the component being inhibited is a cationic amino acid transporter, an arginase, or a component downstream of the
arg nase. In many other embodiments, the activity or expression of the component is i bited by an agent that binds to the component.
In still many other embodiments, the activity or expression of the component is inhibited by an agent that binds a polynucleotide
encoding the component.

Documents

Application Documents

#	Name	Date
1	4697-KOLNP-2007-PRIORITY DOCUMENT.pdf	2011-10-08
2	4697-KOLNP-2007-FORM 3 1.1.pdf	2011-10-08
3	4697-kolnp-2007-form 18.pdf	2011-10-08
4	4697-KOLNP-2007-CORRESPONDENCE OTHERS 1.1.pdf	2011-10-08
5	4697-KOLNP-2007-ASSIGNMENT.pdf	2011-10-08
6	04697-kolnp-2007-sequence listing.pdf	2011-10-08
7	04697-kolnp-2007-gpa.pdf	2011-10-08
8	04697-kolnp-2007-form 5.pdf	2011-10-08
9	04697-kolnp-2007-form 3.pdf	2011-10-08
10	04697-kolnp-2007-form 2.pdf	2011-10-08
11	04697-kolnp-2007-form 1.pdf	2011-10-08
12	04697-kolnp-2007-drawings.pdf	2011-10-08
13	04697-kolnp-2007-description complete.pdf	2011-10-08
14	04697-kolnp-2007-correspondence others.pdf	2011-10-08
15	04697-kolnp-2007-claims.pdf	2011-10-08
16	04697-kolnp-2007-abstract.pdf	2011-10-08
17	4697-KOLNP-2007_EXAMREPORT.pdf	2016-06-30
18	4697-KOLNP-2007-FIRST EXAMINATION REPORT.pdf	2016-10-05
19	4697-KOLNP-2007-ABANDONED LETTER.pdf	2016-10-05
20	FIRST EXAMINATION REPORT.pdf	2016-12-05
21	ABANDONED LETTER.pdf	2016-12-05